CARTER'S INC (CRI) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CRI • US1462291097

38.46 USD
+1.66 (+4.51%)
At close: Feb 4, 2026
38.46 USD
0 (0%)
After Hours: 2/4/2026, 8:12:14 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CRI. CRI was compared to 45 industry peers in the Textiles, Apparel & Luxury Goods industry. CRI has only an average score on both its financial health and profitability. CRI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year CRI was profitable.
  • CRI had a positive operating cash flow in the past year.
  • CRI had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CRI had a positive operating cash flow.
CRI Yearly Net Income VS EBIT VS OCF VS FCFCRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

  • CRI's Return On Assets of 3.52% is fine compared to the rest of the industry. CRI outperforms 62.22% of its industry peers.
  • CRI's Return On Equity of 10.06% is fine compared to the rest of the industry. CRI outperforms 62.22% of its industry peers.
  • CRI's Return On Invested Capital of 6.89% is in line compared to the rest of the industry. CRI outperforms 60.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CRI is above the industry average of 11.60%.
  • The last Return On Invested Capital (6.89%) for CRI is well below the 3 year average (13.75%), which needs to be investigated, but indicates that CRI had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.52%
ROE 10.06%
ROIC 6.89%
ROA(3y)9.05%
ROA(5y)8.18%
ROE(3y)26.4%
ROE(5y)25.22%
ROIC(3y)13.75%
ROIC(5y)13.22%
CRI Yearly ROA, ROE, ROICCRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • CRI has a Profit Margin (3.07%) which is comparable to the rest of the industry.
  • CRI's Profit Margin has declined in the last couple of years.
  • CRI has a Operating Margin of 6.09%. This is comparable to the rest of the industry: CRI outperforms 55.56% of its industry peers.
  • In the last couple of years the Operating Margin of CRI has declined.
  • CRI's Gross Margin of 46.79% is in line compared to the rest of the industry. CRI outperforms 46.67% of its industry peers.
  • CRI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.09%
PM (TTM) 3.07%
GM 46.79%
OM growth 3Y-11.06%
OM growth 5Y-2.63%
PM growth 3Y-12.75%
PM growth 5Y-2.95%
GM growth 3Y0.38%
GM growth 5Y2.29%
CRI Yearly Profit, Operating, Gross MarginsCRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRI is still creating some value.
  • Compared to 1 year ago, CRI has less shares outstanding
  • The number of shares outstanding for CRI has been reduced compared to 5 years ago.
  • The debt/assets ratio for CRI has been reduced compared to a year ago.
CRI Yearly Shares OutstandingCRI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CRI Yearly Total Debt VS Total AssetsCRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • CRI has an Altman-Z score of 2.70. This is not the best score and indicates that CRI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CRI has a Altman-Z score (2.70) which is in line with its industry peers.
  • CRI has a debt to FCF ratio of 5.42. This is a neutral value as CRI would need 5.42 years to pay back of all of its debts.
  • CRI has a Debt to FCF ratio (5.42) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.58 indicates that CRI is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.58, CRI is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 5.42
Altman-Z 2.7
ROIC/WACC0.62
WACC11.11%
CRI Yearly LT Debt VS Equity VS FCFCRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 2.26 indicates that CRI has no problem at all paying its short term obligations.
  • CRI has a better Current ratio (2.26) than 64.44% of its industry peers.
  • CRI has a Quick Ratio of 2.26. This is a bad value and indicates that CRI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of CRI (0.95) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 0.95
CRI Yearly Current Assets VS Current LiabilitesCRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for CRI have decreased strongly by -33.33% in the last year.
  • The Earnings Per Share has been decreasing by -1.36% on average over the past years.
  • Looking at the last year, CRI shows a very negative growth in Revenue. The Revenue has decreased by -19.15% in the last year.
  • Measured over the past years, CRI shows a decrease in Revenue. The Revenue has been decreasing by -4.17% on average per year.
EPS 1Y (TTM)-33.33%
EPS 3Y-8.37%
EPS 5Y-1.36%
EPS Q2Q%-55.95%
Revenue 1Y (TTM)-19.15%
Revenue growth 3Y-6.56%
Revenue growth 5Y-4.17%
Sales Q2Q%-0.08%

3.2 Future

  • The Earnings Per Share is expected to decrease by -23.98% on average over the next years. This is quite bad
  • Based on estimates for the next years, CRI will show a small growth in Revenue. The Revenue will grow by 0.34% on average per year.
EPS Next Y-47.95%
EPS Next 2Y-34.23%
EPS Next 3Y-23.98%
EPS Next 5YN/A
Revenue Next Year2.11%
Revenue Next 2Y1.05%
Revenue Next 3Y0.34%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CRI Yearly Revenue VS EstimatesCRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CRI Yearly EPS VS EstimatesCRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • CRI is valuated reasonably with a Price/Earnings ratio of 9.25.
  • Compared to the rest of the industry, the Price/Earnings ratio of CRI indicates a rather cheap valuation: CRI is cheaper than 88.89% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 28.25. CRI is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 14.65, which indicates a correct valuation of CRI.
  • Based on the Price/Forward Earnings ratio, CRI is valued a bit cheaper than the industry average as 68.89% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.50, CRI is valued a bit cheaper.
Industry RankSector Rank
PE 9.25
Fwd PE 14.65
CRI Price Earnings VS Forward Price EarningsCRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 75.56% of the companies in the same industry are more expensive than CRI, based on the Enterprise Value to EBITDA ratio.
  • 82.22% of the companies in the same industry are more expensive than CRI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.24
EV/EBITDA 7.55
CRI Per share dataCRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • CRI has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as CRI's earnings are expected to decrease with -23.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-34.23%
EPS Next 3Y-23.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.98%, CRI has a reasonable but not impressive dividend return.
  • CRI's Dividend Yield is rather good when compared to the industry average which is at 1.47. CRI pays more dividend than 86.67% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CRI pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.98%

5.2 History

  • On average, the dividend of CRI grows each year by 16.75%, which is quite nice.
  • CRI has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CRI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)16.75%
Div Incr Years1
Div Non Decr Years4
CRI Yearly Dividends per shareCRI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • CRI pays out 87.45% of its income as dividend. This is not a sustainable payout ratio.
  • CRI's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP87.45%
EPS Next 2Y-34.23%
EPS Next 3Y-23.98%
CRI Yearly Income VS Free CF VS DividendCRI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
CRI Dividend Payout.CRI Dividend Payout, showing the Payout Ratio.CRI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CARTER'S INC

NYSE:CRI (2/4/2026, 8:12:14 PM)

After market: 38.46 0 (0%)

38.46

+1.66 (+4.51%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)10-27
Earnings (Next)02-23
Inst Owners114.73%
Inst Owner Change0.27%
Ins Owners2.81%
Ins Owner Change-0.41%
Market Cap1.40B
Revenue(TTM)2.83B
Net Income(TTM)87.00M
Analysts46.15
Price Target30.8 (-19.92%)
Short Float %11.16%
Short Ratio3.48
Dividend
Industry RankSector Rank
Dividend Yield 2.98%
Yearly Dividend3.2
Dividend Growth(5Y)16.75%
DP87.45%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-28.64%
Min EPS beat(2)-56.97%
Max EPS beat(2)-0.32%
EPS beat(4)2
Avg EPS beat(4)-0.02%
Min EPS beat(4)-56.97%
Max EPS beat(4)33.81%
EPS beat(8)6
Avg EPS beat(8)13.85%
EPS beat(12)10
Avg EPS beat(12)20.28%
EPS beat(16)12
Avg EPS beat(16)15.61%
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-2.52%
Max Revenue beat(2)2.56%
Revenue beat(4)2
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-2.52%
Max Revenue beat(4)2.56%
Revenue beat(8)3
Avg Revenue beat(8)-0.06%
Revenue beat(12)5
Avg Revenue beat(12)0.69%
Revenue beat(16)7
Avg Revenue beat(16)0.1%
PT rev (1m)4.86%
PT rev (3m)10.22%
EPS NQ rev (1m)16.34%
EPS NQ rev (3m)2.76%
EPS NY rev (1m)7.69%
EPS NY rev (3m)-0.12%
Revenue NQ rev (1m)2.66%
Revenue NQ rev (3m)3.86%
Revenue NY rev (1m)0.83%
Revenue NY rev (3m)1.04%
Valuation
Industry RankSector Rank
PE 9.25
Fwd PE 14.65
P/S 0.49
P/FCF 15.24
P/OCF 9.27
P/B 1.62
P/tB 3.82
EV/EBITDA 7.55
EPS(TTM)4.16
EY10.82%
EPS(NY)2.63
Fwd EY6.83%
FCF(TTM)2.52
FCFY6.56%
OCF(TTM)4.15
OCFY10.78%
SpS77.71
BVpS23.72
TBVpS10.06
PEG (NY)N/A
PEG (5Y)N/A
Graham Number47.12
Profitability
Industry RankSector Rank
ROA 3.52%
ROE 10.06%
ROCE 8.76%
ROIC 6.89%
ROICexc 7.6%
ROICexgc 10.55%
OM 6.09%
PM (TTM) 3.07%
GM 46.79%
FCFM 3.25%
ROA(3y)9.05%
ROA(5y)8.18%
ROE(3y)26.4%
ROE(5y)25.22%
ROIC(3y)13.75%
ROIC(5y)13.22%
ROICexc(3y)16.52%
ROICexc(5y)18.31%
ROICexgc(3y)24.79%
ROICexgc(5y)28.26%
ROCE(3y)17.48%
ROCE(5y)16.81%
ROICexgc growth 3Y-19.15%
ROICexgc growth 5Y0.36%
ROICexc growth 3Y-17.36%
ROICexc growth 5Y-0.7%
OM growth 3Y-11.06%
OM growth 5Y-2.63%
PM growth 3Y-12.75%
PM growth 5Y-2.95%
GM growth 3Y0.38%
GM growth 5Y2.29%
F-Score5
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 5.42
Debt/EBITDA 2.19
Cap/Depr 107.95%
Cap/Sales 2.09%
Interest Coverage 250
Cash Conversion 66.51%
Profit Quality 105.72%
Current Ratio 2.26
Quick Ratio 0.95
Altman-Z 2.7
F-Score5
WACC11.11%
ROIC/WACC0.62
Cap/Depr(3y)84.08%
Cap/Depr(5y)65.4%
Cap/Sales(3y)1.75%
Cap/Sales(5y)1.49%
Profit Quality(3y)119.52%
Profit Quality(5y)187.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-33.33%
EPS 3Y-8.37%
EPS 5Y-1.36%
EPS Q2Q%-55.95%
EPS Next Y-47.95%
EPS Next 2Y-34.23%
EPS Next 3Y-23.98%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.15%
Revenue growth 3Y-6.56%
Revenue growth 5Y-4.17%
Sales Q2Q%-0.08%
Revenue Next Year2.11%
Revenue Next 2Y1.05%
Revenue Next 3Y0.34%
Revenue Next 5YN/A
EBIT growth 1Y-52.45%
EBIT growth 3Y-16.9%
EBIT growth 5Y-6.69%
EBIT Next Year-14.36%
EBIT Next 3Y-0.61%
EBIT Next 5YN/A
FCF growth 1Y-79.82%
FCF growth 3Y1.66%
FCF growth 5Y-5.73%
OCF growth 1Y-70.46%
OCF growth 3Y3.65%
OCF growth 5Y-5.05%

CARTER'S INC / CRI FAQ

What is the ChartMill fundamental rating of CARTER'S INC (CRI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRI.


What is the valuation status of CARTER'S INC (CRI) stock?

ChartMill assigns a valuation rating of 6 / 10 to CARTER'S INC (CRI). This can be considered as Fairly Valued.


What is the profitability of CRI stock?

CARTER'S INC (CRI) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CRI stock?

The Price/Earnings (PE) ratio for CARTER'S INC (CRI) is 9.25 and the Price/Book (PB) ratio is 1.62.


How financially healthy is CARTER'S INC?

The financial health rating of CARTER'S INC (CRI) is 5 / 10.